Germany

Pic:getty/palto

Sartorius acquires majority stake in CellGenix

By Rachel Arthur

Sartorius is strengthening its product portfolio for cell and gene therapies with the acquisition of a majority stake in German reagent manufacturer CellGenix.

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All suppliers